Tissue Yields for Epidermal Growth Factor Receptor Analysis in Non-Small Cell Lung Cancer Patients in Trinidad and Tobago

Introduction Patients with unresectable non-small cell lung cancer (NSCLC) may benefit from chemotherapy, tyrosine kinase inhibitor (TKI) therapy, or both. TKI therapy may be administered to the subset of patients who harbor the epidermal growth factor receptor (EGFR) mutation. EGFR mutation testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Haralsingh, Aaron, West, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiac/Thoracic/Vascular Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788053/
https://www.ncbi.nlm.nih.gov/pubmed/33425564
http://dx.doi.org/10.7759/cureus.12531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788053/
https://www.ncbi.nlm.nih.gov/pubmed/33425564
http://dx.doi.org/10.7759/cureus.12531

Ejemplares similares